Skip to main content

MoneyWorks4Me

Granules India informs about press release

14 Jun 2023 Evaluate

Granules India has informed that it enclosed the press release dated on 14th June 2023, titled ‘Granules India Limited Receives ANDA Approval for Levetiracetam Tablets in record 9 months.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..